Small molecules for bone diseases. - Wikidata - awgldk - TriplyDB

Small molecules for bone diseases.

Small molecules for bone diseases.

http://www.wikidata.org/entity/Q37714909

about

Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.One-day treatment of small molecule 8-bromo-cyclic AMP analogue induces cell-based VEGF production for in vitro angiogenesis and osteoblastic differentiation.

P2860

Q38008692-44C9EB5F-AE47-4D8A-AF44-9E20B5EC8168 Q41554303-6E475FAF-37A2-46D6-9D9A-6FB678DBB245

P2860

Small molecules for bone diseases.

http://www.wikidata.org/entity/Q37714909

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Small molecules for bone diseases.

@en

Small molecules for bone diseases.

@nl

type

label

Small molecules for bone diseases.

@en

Small molecules for bone diseases.

@nl

prefLabel

Small molecules for bone diseases.

@en

Small molecules for bone diseases.

@nl

P1433

Q37714909-3AD5EDD9-EB4C-48CF-AEDD-623285C88E78

P1476

Q37714909-A309BE7A-91D7-42BB-8E90-38938B624FD2

P2093

Q37714909-6537C540-0332-43B5-BB09-8D3A30ADB959

Q37714909-ABAD068C-DFEF-4FA7-A190-6088FF20A48A

P2860

Q37714909-06EAF26B-A180-43FC-8CC6-4BF8FF5AB963

Q37714909-09102908-79CA-4152-9B9A-FE8FD415D6C8

Q37714909-0BB966D6-5449-4584-96E1-AD2D0E592969

Q37714909-0EDC65C7-B3BA-44FF-B5D2-6824AA32C264

Q37714909-128B4EFF-2AFE-425B-8736-907974A969CF

Q37714909-166A7F32-18EF-4F48-B1E2-592C0882759C

Q37714909-167D898B-FF51-4CE4-880E-567150EB8A24

Q37714909-17CCB1D3-7239-474A-B737-B6AE4DDC9B10

Q37714909-243D213E-FC9C-4974-BD15-21B3D0AC179B

Q37714909-255A0CA2-C0D3-4069-921F-1907C844F0F3

P304

Q37714909-B3E39EAF-1381-441F-A622-3AB7E1892D8A

P31

Q37714909-59D14D99-57C4-411D-B400-5C188E98A930

P356

Q37714909-15EB0CF0-B03A-4475-AE07-27F7D4D71D7D

P407

Q37714909-F317D782-13D3-4000-BB5B-B58BB43A6100

P433

Q37714909-5709221F-F4B2-4B45-A687-903BB33635A6

P478

Q37714909-B2E42749-9F9F-4DF7-AD6E-FFB75AFB116A

P577

Q37714909-2451548A-D6F0-4C86-A9BF-A495EABD1E06

P698

Q37714909-D6B644A1-C0E0-4E2F-AE28-278966EDA267

P356

13543771003604729

P1433

Expert Opinion on Therapeutic Patents

P1476

Small molecules for bone diseases.

@en

P2093

Keiichi Masuya

http://www.w3.org/2001/XMLSchema#string

Naoki Teno

http://www.w3.org/2001/XMLSchema#string

P2860

Development of bisphosphonates.

Regulation and enzymatic basis of bone resorption by human osteoclasts

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides

Osteoclasts: what do they do and how do they do it?

Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13

The amino-terminal domain of the B subunit of vacuolar H+-ATPase contains a filamentous actin binding site

Irreversible inhibitors of serine, cysteine, and threonine proteases

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

P304

563-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543771003604729

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20302452

http://www.w3.org/2001/XMLSchema#string